Doctors--the duped drug suppliers. Part Ii
Hunziker, C.
Minnesota Medicine 67(1): 31
1984
ISSN/ISBN: 0026-556X PMID: 6140624 Document Number: 237641
Document emailed within 1 workday
Related Documents
Hunziker, C. 1982: Doctors--the duped drug suppliers? Minnesota Medicine 65(7): 425Hamilton, D.G. 1986: Australian doctors and the visual arts. Part 4. Doctors as supporters of art galleries and artists in Victoria Medical Journal of Australia 145(1): 38-40
McCarthy, M. 2014: Drug firms cut doctors' fees for drug talks Bmj 348: G2021
Stephenson, L. 2005: Medicare part D--what doctors need to know Iowa Medicine: Journal of the Iowa Medical Society 95(6): 24-25
Gardner, J. 1997: Fighting for Part A. Vulnerable doctors go after hospital Medicare funds Modern Healthcare 27(29): 16
Moore, J.; Gale, J.; Dew, K.; Simmers, D. 2006: Student debt amongst junior doctors in new Zealand; part 2: effects on intentions and workforce New Zealand Medical Journal 119(1229): U1854
Wheeler, R.; Candib, L.; Martin, M. 1990: Part-time doctors: reduced working hours for primary care physicians Journal of the American Medical Women's Association 45(2): 47-54
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Moore, J.; Gale, J.; Dew, K.; Davie, G. 2006: Student debt amongst junior doctors in new Zealand; part 1: quantity, distribution, and psychosocial impact New Zealand Medical Journal 119(1229): U1853
Chren, M.M.; Landefeld, C.S. 1991: Doctors, drug companies and gifts Rhode Island Medical Journal 74(12): 603-610
Hobbs, T.R. 1998: Drug diversion and prescription drug abuse--Part i Pennsylvania Medicine 101(10): 15
Charatan, F. 2001: Doctors say they are not influenced by drug companies' promotions Bmj 322(7294): 1081
Yamey, G. 2001: Pen "amnesty" for doctors who shun drug companies Bmj 322(7278): 69
Crowley, T.J. 1985: Doctors' drug abuse reduced during contingency-contracting treatment Alcohol and Drug Research 6(4): 299-307
Gardner, N. 1999: The doc stops here. Arkansas Medical Foundation helps doctors end drug abuse Journal of the Arkansas Medical Society 96(7): 245-247
McCarthy, M. 2014: US intends to publish drug company payments to doctors from October despite calls for delay Bmj 349: G5693
Valero Martín, A.; Jiménez Luque, J.M.; Ranz, F.B.; Lora, N.; Pérula de Torres, L.A.; Serrano Varo, P. 1993: Approximation to the detection of drug adverse reactions among doctors at the primary health care level Atencion Primaria 11(2): 76-80
Corfitzen, M.V. 1990: Nurses as consumers and suppliers Sygeplejersken 90(44): 22-23
Reinhardt, D.; Richter, O. 1981: Drug effects on embryo and fetus. Part 1: Teratogenic and toxic drug effects Fortschritte der Medizin 99(24): 963-968
Trombetta, W.L.; Sweeney, D.R. 1986: Ties that bind: new roles for suppliers Pennsylvania Medicine 89(6): 54; 56